DYN   $18.16  -1.04% Market Closed After Close 18.16 0.0

Dyne Therapeutics, Inc.
Total Cash 778.84M
totalCashPerShare 7.757
EBITDA -269.47M
Total Debt 25.72M
quickRatio 26.177
currentRatio 26.63
Total Revenue
debtToEquity 3.317
Revenue/Share
ROA -0.31454
ROE -0.52459997
grossProfits
freeCashflow -130.44M
operatingCashflow -219.01M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.12B
forwardPE -9.433544
floatShares 73.76M
sharesOutstanding 100.40M
sharesShort 9.11M
sharesShortPriorMonth 7.66M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.15%
Short Ratio help_outline 8.21%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 7.743
Price To Book help_outline 3.85
earningsQuarterlyGrowth
netIncomeToCommon -257.60M
trailingEps -3.58%
forwardEps -3.16%
enterpriseToEbitda -7.87
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.71 3Q 2024
institutionsCount 284
lastUpdated Nov. 7, 2024, 3:25 a.m.